Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24741355 | 1.00 | KMT2A (0.45) | KMT2AMEN1CYP2C19CYP2C9EHMT2 | |
| SCHEMBL5739211 | 1.00 | KMT2A (0.45) | KMT2AMEN1CYP2C19CYP2C9EHMT2 | |
| SCHEMBL9679547 | 1.00 | KMT2A (0.45) | KMT2AMEN1CYP2C19CYP2C9EHMT2 | |
| SCHEMBL5739207 | 1.00 | KMT2A (0.45) | KMT2AMEN1CYP2C19CYP2C9EHMT2 | |
| SCHEMBL38657586 | 1.00 | KMT2A (0.45) | KMT2AMEN1CYP2C19CYP2C9EHMT2 | |
| SCHEMBL9737057 | 0.85 | CYP2C9 (0.46) | KMT2AMEN1CYP2C19CYP2C9EHMT2 | |
| SCHEMBL30480079 | 0.85 | CYP2C9 (0.46) | KMT2AMEN1CYP2C19CYP2C9EHMT2 | |
| SCHEMBL9737464 | 0.85 | CYP2C9 (0.46) | KMT2AMEN1CYP2C19CYP2C9EHMT2 | |
| SCHEMBL9738098 | 0.82 | EHMT2 (0.46) | KMT2AMEN1CYP2C19CYP2C9EHMT2 | |
| SCHEMBL10072991 | 0.82 | KMT2A (0.55) | KMT2AMEN1POLBSMN1; SMN2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3052473-B1 | A PROCESS FOR THE PREPARATION OF INTERMEDIATE FOR THE PREPARATION OF OSELTAMIVIR PHOSPHATE | COUNCIL SCIENT IND RES (IN) | 2018-01-17 | — | — | EP | disclosed |
| US-9522922-B2 | Process for the preparation of intermediate for the preparation of oseltamivir phosphate | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2016-12-20 | — | — | US | disclosed |
| US-20160222029-A1 | A PROCESS FOR THE PREPARATION OF INTERMEDIATE FOR THE PREPARATION OF OSELTAMIVIR PHOSPHATE | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2016-08-04 | — | — | US | disclosed |
| EP-0415166-B1 | Process for the preparation of cyanohydantoines | MERCK PATENT GMBH (DE) | 1996-11-20 | — | — | EP | disclosed |
| US-5095118-A | PROCESS FOR THE PREPARATION OF D-(+)-BIOTIN | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1992-03-10 | — | — | US | disclosed |
| EP-0242686-B1 | PROCESS FOR THE PREPARATION OF D-(+)-BIOTINE | MERCK PATENT GmbH (DE) | 1992-01-29 | — | — | EP | disclosed |
| EP-0415166-A2 | Process for the preparation of cyanohydantoines | MERCK PATENT GmbH (DE) | 1991-03-06 | — | — | EP | disclosed |
| US-4937351-A | Process for the preparation of D-(+)-biotin | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1990-06-26 | — | — | US | disclosed |
| US-4877882-A | Process for the preparation of D-(+)-biotin | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1989-10-31 | — | — | US | disclosed |
| US-4837402-A | Process for the preparation of D-(+)-biotin | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1989-06-06 | — | — | US | disclosed |
| US-4732987-A | Process for the preparation of D-(+)-biotin | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1988-03-22 | — | — | US | disclosed |
| EP-0242686-A2 | Process for the preparation of D-(+)-biotine | MERCK PATENT GmbH (DE) | 1987-10-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160222029-A1 | A PROCESS FOR THE PREPARATION OF INTERMEDIATE FOR THE PREPARATION OF OSELTAMIVIR PHOSPHATE | OSGEP, CYP2B6, CYP2F1 | KMT2A 1993/4885MEN1 4075/4885CYP2C19 27/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.